FDA Accepts New Drug Application for Triple Combination Tablet for Adults with Type 2 Diabetes Read more
FDA approves first treatment for episodic cluster headache that reduces the frequency of attacks Read more
AstraZeneca to lead a workshop during the Wearable Injectors and Connected Devices Conference 2019 Read more
Thermo Fisher Scientific Announces Collaboration with Newomics to Advance Disease Biomarker Validation Read more
FDA Approves Merck’s ZERBAXA (ceftolozane and tazobactam) 3g Dose for the Treatment of Adults with HABP/VABP Read more